Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Two-year cumulative risk of target vessel revascularization in patients treated with bare stents before the introduction of sirolimus-eluting stents (SES) (pre-SES group) and in patients treated exclusively with SES implantation (SES group).
|
